LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Radicicol | 3.33 | uM | LJP6 | 72 | hr | 1334 | 980 | 3970 | 0.2470 | -0.1343 |
BT-20 | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 1334 | 3442 | 3970 | 0.8668 | 0.7994 |
BT-20 | Ruxolitinib | 3.33 | uM | LJP5 | 72 | hr | 1334 | 3901 | 3970 | 0.9825 | 0.9736 |
BT-20 | XL147 | 3.33 | uM | LJP5 | 72 | hr | 1334 | 3528 | 3970 | 0.8886 | 0.8322 |
BT-20 | Saracatinib | 3.33 | uM | LJP6 | 72 | hr | 1334 | 3169 | 3970 | 0.7982 | 0.6961 |
BT-20 | Selumetinib | 3.33 | uM | LJP6 | 72 | hr | 1334 | 3760 | 3970 | 0.9470 | 0.9201 |
BT-20 | Sirolimus | 3.33 | uM | LJP6 | 72 | hr | 1334 | 2448 | 3970 | 0.6166 | 0.4224 |
BT-20 | Sorafenib | 3.33 | uM | LJP6 | 72 | hr | 1334 | 3523 | 3970 | 0.8873 | 0.8302 |
BT-20 | SU11274 | 3.33 | uM | LJP5 | 72 | hr | 1334 | 3456 | 3970 | 0.8703 | 0.8047 |
BT-20 | Fedratinib | 3.33 | uM | LJP5 | 72 | hr | 1334 | 2986 | 3970 | 0.7521 | 0.6265 |
BT-20 | TGX221 | 3.33 | uM | LJP5 | 72 | hr | 1334 | 4317 | 3970 | 1.0872 | 1.1313 |
BT-20 | Torin1 | 3.33 | uM | LJP6 | 72 | hr | 1334 | 1086 | 3970 | 0.2736 | -0.0942 |
BT-20 | Torin2 | 3.33 | uM | LJP5 | 72 | hr | 1334 | 631 | 3970 | 0.1590 | -0.2668 |
BT-20 | Tozasertib | 3.33 | uM | LJP5 | 72 | hr | 1334 | 1025 | 3970 | 0.2581 | -0.1175 |
BT-20 | Trametinib | 3.33 | uM | LJP5 | 72 | hr | 1334 | 3106 | 3970 | 0.7823 | 0.6720 |
BT-20 | TWS119 | 3.33 | uM | LJP5 | 72 | hr | 1334 | 3239 | 3970 | 0.8158 | 0.7225 |
BT-20 | Vemurafenib | 3.33 | uM | LJP5 | 72 | hr | 1334 | 3595 | 3970 | 0.9055 | 0.8577 |
BT-20 | Withaferin A | 3.33 | uM | LJP5 | 72 | hr | 1334 | 647 | 3970 | 0.1629 | -0.2609 |
BT-20 | Withaferin A | 3.33 | uM | LJP6 | 72 | hr | 1334 | 504 | 3970 | 0.1271 | -0.3149 |
BT-20 | WYE-125132 | 3.33 | uM | LJP6 | 72 | hr | 1334 | 1586 | 3970 | 0.3996 | 0.0956 |
BT-20 | WZ3105 | 3.33 | uM | LJP5 | 72 | hr | 1334 | 518 | 3970 | 0.1305 | -0.3098 |
BT-20 | XMD11-50 | 3.33 | uM | LJP6 | 72 | hr | 1334 | 2989 | 3970 | 0.7527 | 0.6275 |
BT-20 | Y39983 | 3.33 | uM | LJP6 | 72 | hr | 1334 | 3643 | 3970 | 0.9175 | 0.8757 |
BT-20 | YM 201636 | 3.33 | uM | LJP5 | 72 | hr | 1334 | 2784 | 3970 | 0.7011 | 0.5498 |
BT-20 | ZSTK474 | 3.33 | uM | LJP6 | 72 | hr | 1334 | 1881 | 3970 | 0.4738 | 0.2074 |